-
Federal
Growth factors in idiopathic pulmonary fibrosis: relative roles
U.S. Department of Health & Human Services —
Treatment of idiopathic pulmonary fibrosis patients has evolved very slowly; the fundamental approach of corticosteroids alone or in combination with other... -
Federal
Therapeutic angiogenesis for cardiovascular disease
U.S. Department of Health & Human Services —
The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to... -
Federal
Latent transforming growth factor β-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor
U.S. Department of Health & Human Services —
Background The membrane-bound cell-surface precursor and soluble forms of heparin-binding epidermal growth factor-like growth factor (HB-EGF) contribute to many... -
Federal
Nucleolar localization of an isoform of the IGF-I precursor
U.S. Department of Health & Human Services —
Background Alternative exons encode different isoforms of the human insulin-like growth factor-I (IGF-I) precursor without altering mature IGF-I. We hypothesized that... -
Federal
Growth factors in lung development and disease: friends or foe?
U.S. Department of Health & Human Services —
Growth factors mediate tissue interactions and regulate a variety of cellular functions that are critical for normal lung development and homeostasis. Besides their...